Svetlana Sergeyevna Zubritskaya
Directeur/Membre du Conseil chez SynBio LLC
Provenance du réseau au premier degré de Svetlana Sergeyevna Zubritskaya
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
SynBio LLC
 SynBio LLC Pharmaceuticals: MajorHealth Technology SynBio LLC engages in original research and introduction of conceptually new medicines. The firm’s medicines help treat diseases like liver disease, cardiovascular disease, acute leukemia, growth hormone deficiency and diabetes milletus. Its work is based on scientific developments and conducted in cutting edge laboratories. The company was founded in 2011 and is headquartered in Moscow, Russian Federation.
7
| Subsidiary | Pharmaceuticals: Major | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Svetlana Sergeyevna Zubritskaya via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| PHARMSYNTHEZ | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
Xenetic Biosciences (UK) Ltd.
 Xenetic Biosciences (UK) Ltd. Pharmaceuticals: MajorHealth Technology Xenetic Biosciences (UK) Ltd. is engaged in the development of drug and vaccine delivery systems and proprietary products in the fields of protein drugs, vaccines and oncology. It provides specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology. The company's product pipeline includes polyxen, imuxen and oncohist. Xenetic Biosciences was founded by Gregory Gregoriadis on June 24, 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Peri-Ness Technologies Ltd.
 Peri-Ness Technologies Ltd. Pharmaceuticals: MajorHealth Technology Peri-Ness Technologies Ltd. operates as a biotechnology company focusing on addressing the problems of male fertility. The firm’s product is a systemic protein-based drug for treatment of male sub-fertility. The company was founded by Benjamin Bartoov, Attar Michal Ben, Dobroslav Melamed and Moshe Mizrahy in 2006 and is headquartered in Givat Shmuel, Israel. | Pharmaceuticals: Major | Director/Board Member | |
PET-Technology OOO
 PET-Technology OOO Medical SpecialtiesHealth Technology PET-Technology OOO operates as a network of nuclear medicine centers. It provides positron emission and computerized tomography, as well as cyberknife treatment services. The company was founded on September 1, 2011 and is headquartered in Moscow, Russia. | Medical Specialties | Director/Board Member | |
RUSNANO Projects
 RUSNANO Projects Investment ManagersFinance Rusnano Projects is a private equity and venture capital operating division of the State-owned Rusnano OJSC. The firm was founded in 2007 and is headquartered in Moscow, Russia. | Investment Managers | Private Equity Investor | |
Nearmedic Pharma Ltd.
 Nearmedic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Nearmedic Pharma Ltd. develops pharmaceutical products. The company is headquartered in Obninsk, Russian Federation | Pharmaceuticals: Major | Director/Board Member | |
| Pavlov First Saint Petersburg State Medical University | College/University | Undergraduate Degree | |
| Pharmavit Holding | Corporate Officer/Principal | ||
| H & H LLC | Director/Board Member | ||
| CLS THERAPEUTICS, INC. | Director/Board Member | ||
| The School of Pharmacy University of London | College/University | Graduate Degree | |
SANTERSUS AG
 SANTERSUS AG Medical SpecialtiesHealth Technology SANTERSUS AG is a Swiss therapeutic apheresis company that focuses on cleansing patient blood through the selective extra corporeal removal of neutrophil extracellular traps (NETs). The private company is located in Switzerland. NETs are fibers produced by neutrophils, which are the largest fraction of white blood cells produced by the bone marrow. The company is developing a novel patent-protected transformative, lifesaving, blood purification device for use in the treatment of sepsis, autoimmune diseases, cancer, and COVID-19. | Medical Specialties | Founder | |
| HUMAN STEM CELLS INSTITUTE | Medical/Nursing Services | Director/Board Member | |
| University College London | College/University | Corporate Officer/Principal | |
| XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
Kevelt AS
 Kevelt AS Pharmaceuticals: MajorHealth Technology Part of Pharmsynthez PJSC, Kevelt AS is an Estonian company that manufactures and distributes pharmaceutical products. The company is based in Tallinn, Estonia. Kevelt was acquired by Pharmsynthez PJSC on January 17, 2011. | Pharmaceuticals: Major | Director/Board Member | |
| Mechnikov St Petersburg State Medical Academy | College/University | Undergraduate Degree | |
FDS Pharma LLP
 FDS Pharma LLP Pharmaceuticals: MajorHealth Technology FDS Pharma LLP manufactures pharmaceutical products. The company was founded on March 28, 1996 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer | |
EPhaG AS
 EPhaG AS Drugstore ChainsRetail Trade Part of Firebird Management Partners LP, EPhaG AS is a holding Estonian company for pharmacies. The company is based in Viimsi Harjumaa, Estonia. | Drugstore Chains | Director/Board Member | |
| FDS Pharma Associates Ltd. | Director/Board Member | ||
| DAEHO AL CO.,LTD. | Aluminum | Director/Board Member |
Statistiques
Internationale
| Russie | 11 |
| Royaume-Uni | 5 |
| Etats-Unis | 3 |
| Estonie | 3 |
| Israël | 2 |
Sectorielle
| Health Technology | 10 |
| Consumer Services | 5 |
| Finance | 2 |
| Health Services | 2 |
| Retail Trade | 2 |
Opérationnelle
| Director/Board Member | 22 |
| Corporate Officer/Principal | 4 |
| Undergraduate Degree | 2 |
| Chief Executive Officer | 2 |
| Chairman | 2 |
Relations les plus connectées
- Bourse
- Insiders
- Svetlana Sergeyevna Zubritskaya
- Connexions Sociétés
